The penny stock craze of the ’80s gave her a eureka moment. "A lot of people gave their money up because of this glamorous idea of investing and reaping great rewards," she said. Omer Ben Seadia (Photo: Submitted) In the same …
Omeros Corporation settled patent dispute, removing threat to Omidria. The company reported positive results for its lead drug candidate OMS721. The stock momentum is likely to be sustained as the company benefits from recent fund …
LONDON, UK / ACCESSWIRE / May 18, 2017 / Active Wall St. blog coverage looks at the headline from Omeros Corp. …
If the back injury flares up again—as back injuries are wont to do—how will that …
Just Monday, when Japanese traders were out to celebrate National Foundation Day, analysts had flagged the yen as an indicator of whether the stock market …
Omeros Corporation ( OMER) was a big mover last session, as the company saw its shares rise almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
Shares of Omeros Corporation (NASDAQ: OMER), a rising star in the biotech industry, are losing altitude after the company reported first-quarter earnings today. The stock was down 16% earlier this morning, but just 11.4% lower than …
If the stock closes at or above $12 at expiration this trade will return 11.31% or 20.86% (for comparison purposes only). OMER closed Jan 30, 2018's trading session at $16.57. In the past year, the stock has hit a 52-week low of $9.07 and …
One of Omeros' competitors within the Biotechnology space, Halozyme Therapeutics, Inc. (NASDAQ: HALO), reported …